Comparison of Efficacy and Safety of Biphasic Insulin Aspart 30 [insulin aspart/insulin protamine aspart] and Biphasic Human Insulin 30/70 [insulin aspart/insulin protamine aspart] in Diabetes Mellitus.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 15 May 2009 Actual patient number (219) added as reported by ClinicalTrials.gov.
- 15 May 2009 Actual end date (Nov 2003) added as reported by ClinicalTrials.gov.